Found 4147 chains in Genus chains table. Displaying 2101 - 2150. Applied filters: Proteins

Search results query: Phosphorylase Kinase; domain 1

Total Genus Sequence Length pdb Title
76 233 4fe2A X-ray structure of saicar synthetase (purc) from streptococcus pneumoniae complexed with air, adp, asp and mg2+
76 296 4fktA Crystal structure of the cdk2 in complex with oxindole inhibitor
114 355 3r63A Structure of erk2 (spe) mutant (s246e)
86 273 4fl1A Structural and biophysical characterization of the syk activation switch
73 300 3r2yA Mk2 kinase bound to compound 1
79 274 3r01A The discovery of novel benzofuran-2-carboxylic acids as potent pim-1 inhibitors
71 235 4fgrA X-ray structure of saicar synthetase (purc) from streptococcus pneumoniae complexed with adp and mg2+
82 298 4fkuA Crystal structure of the cdk2 in complex with oxindole inhibitor
84 298 3r73A Cdk2 in complex with inhibitor kvr-1-164
85 292 4fk6A Jak1 kinase (jh1 domain) in complex with compound 72
93 292 4fihA Catalytic domain of human pak4 with qkftglprqw peptide
81 271 3r04A The discovery of novel benzofuran-2-carboxylic acids as potent pim-1 inhibitors
180 627 4fl3A Structural and biophysical characterization of the syk activation switch
74 253 4feuA Crystal structure of the aminoglycoside phosphotransferase aph(3')-ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone sp600125
114 346 3qywA Crystal structure of erk2 in complex with an inhibitor
129 371 4fi1A Crystal structure of scck2 alpha in complex with atp
96 292 4fiiA Catalytic domain of human pak4 with rpkplvdp peptide
79 274 3r00A The discovery of novel benzofuran-2-carboxylic acids as potent pim-1 inhibitors
75 290 4fg8A Crystal structure of human calcium/calmodulin-dependent protein kinase i 1-315 in complex with atp
95 312 4fnxA Crystal structure of the apo r1275q anaplastic lymphoma kinase catalytic domain
73 300 3r30A Mk2 kinase bound to compound 2
87 298 4fklA Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor
80 298 3r1qA Cdk2 in complex with inhibitor kvr-1-102
91 293 4figA Catalytic domain of human pak4
179 627 4fl2A Structural and biophysical characterization of the syk activation switch
82 267 4fevA Crystal structure of the aminoglycoside phosphotransferase aph(3')-ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine pp1
83 298 4fkoA Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor
84 298 4fkqA Crystal structure of the cdk2 in complex with oxindole inhibitor
83 298 4fkiA Crystal structure of the cdk2 in complex with aminopyrazole inhibitor
82 274 3qf9A Crystal structure of human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and a furan-thiazolidinedione ligand
106 349 3queA Human p38 map kinase in complex with skepinone-l
81 286 3qcxA Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 6-{2-amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3-amine
78 295 3qquA Cocrystal structure of unphosphorylated igf with pyrimidine 8
103 414 3qfvA Mrck beta in complex with tpca-1
83 298 3qtuA Cdk2 in complex with inhibitor rc-2-132
78 298 3qu0A Cdk2 in complex with inhibitor rc-2-38
78 332 3qd2B Crystal structure of mouse perk kinase domain
84 270 3qrkA The crystal structure of human abl1 kinase domain in complex with dp-987
78 298 3qqkA Cdk2 in complex with inhibitor l4
81 298 3ql8A Cdk2 in complex with inhibitor jws-6-260
73 298 3qzfA Cdk2 in complex with inhibitor jws-6-52
86 298 3qhwA Structure of a pcdk2/cyclina transition-state mimic
78 298 3qtzA Cdk2 in complex with inhibitor rc-2-36
83 298 3qqfA Cdk2 in complex with inhibitor l1
83 298 3qqjA Cdk2 in complex with inhibitor l2
82 298 3qxoA Cdk2 in complex with inhibitor kvr-1-84
107 351 3qudA Human p38 map kinase in complex with 2-amino-phenylamino-benzophenone
88 286 3qcyA Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 4-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-n-phenyl-2-morpholinecarboxamide
81 298 3qtsA Cdk2 in complex with inhibitor rc-2-12
84 298 3qqhA Cdk2 in complex with inhibitor l2-2